Marpai, Inc. Secures Additional Investment of $200,000 from HillCour Investment Fund

Marpai, Inc. Receives Additional $200,000 Investment from HillCour Investment Fund

TAMPA, Fla. – Marpai, Inc. (OTCQX: MRAI), an independent Third-Party Administration (TPA) company focused on delivering innovative healthcare solutions, has announced a new private placement, raising an additional $200,000 through the sale of 147,058 shares of common stock to HillCour Investment Fund, LLC, which is managed by the company’s CEO, Damien Lamendola.

The shares were offered at a price of $1.36 each, contributing to the company’s overall funding raised in the third quarter of 2025, which totals $1.7 million. These funds are earmarked for general corporate purposes, which include the acceleration of product deployment, enhancement of Marpai's technology platform, and increasing market penetration among self-funded employer groups across the nation.

Damien Lamendola expressed his commitment to the company’s mission, stating, "I continue to invest in Marpai because I believe in what we're building—smarter healthcare, better outcomes, and a scalable platform that’s disrupting a massive market. My personal commitment—financial and operational—reflects my deep confidence in our team, our technology, and our ability to execute on a growth strategy that I believe will lead to sustainable profitability. I am all in."

This investment marks a significant step for Marpai, which is strategically positioned within the competitive landscape of the $150 billion TPA sector and the $550 billion Pharmacy Benefit Management (PBM) industry. The company serves self-funded employer health plans, which collectively represent over $1.5 trillion in annual claims. Through its innovative Marpai Saves initiative, the company aims to provide the healthiest member population for health plan budgets while leveraging its partnerships with leading provider networks, such as Cigna, to offer comprehensive TPA services nationwide.

The funding will enable Marpai to further develop its proprietary technology, streamline operations, and enhance its service offerings to better meet the growing demands of the healthcare market. The company has positioned itself as a pioneer in smart healthcare solutions, with an emphasis on producing measurable results for its clients.

Investors interested in tracking Marpai's progress are encouraged to visit its Investor Relations page at Marpai Health.

However, it’s important to note that this private placement is being made in accordance with exemptions from registration requirements as laid out in the Securities Act of 1933 and may not be offered or sold in the United States without proper compliance with applicable laws. Thus, these shares cannot be marketed or sold in jurisdictions where it would be deemed illegal without prior registration.

In summary, Marpai's commitment to innovating within the healthcare sector and its ability to attract significant investments reflects a robust strategy aimed at achieving long-term sustainability and growth. The ongoing support from key stakeholders like HillCour Investment Fund signifies strong confidence in Marpai's future potential and market disruption capabilities.